Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More
Ashish Kyal of wavesstrategy.com advises buying Ajanta Pharma with a target of Rs 1785.
Ashwani Gujral of ashwanigujral.com recommends buying Ajanta Pharma, IIFL and Bajaj Finance.
Here are a few top buzzing midcap stocks picked by CNBC-TV18's analysts in trade today. We have Reliance, Ajanta Pharma, ONGC, Oil India, Moschip Semiconductor, SBBJ and Supreme Infra.
Sudarshan Sukhani of s2analytics.com is of the view that one can buy Ajanta Pharma, Godrej Industries and UltraTech Cement.
Ashwani Gujral of ashwanigujral.com recommends buying Sun Pharma, Lupin and Dr Reddy's Laboratories on declines.
Sandeep Wagle of powermywealth.com recommends buying BEML, Syndicate Bank and Ajanta Pharma.
Ruchit Jain of Angel Broking is of the view that one may buy Jet Airways with a target of Rs 604.
Ashwani Gujral of ashwanigujral.com is of the view that one can buy Eicher Motors, JSW Steel, Ajanta Pharma and Tata Motors.
Ashwani Gujral of ashwanigujral.com is of the view that Strides Shasun may test Rs 1350-1400.
Sameet Chavan of Angel Broking suggests buying Apollo Tyres with a target of Rs 157.
Ashwani Gujral of ashwanigujral.com is of the view that one can buy India Cements, Ajanta Pharma and ITC.
Prakash Gaba of prakashgaba.com recommends buying Britannia Industries and likes Aditya Birla Nuvo and Ajanta Pharma.
Shahina Mukadam, Independent Market Expert is of the view that one may buy Allcargo Global with a target of Rs 180.
Ashwani Gujral of ashwanigujral.com recommends buying Ajanta Pharma, India Cements and Dabur India.
Sandeep Wagle of powermywealth.com is of the view that one can sell JSW Energy and Ajanta Pharma and buy Hexaware Technologies.
Ashwani Gujral of ashwanigujral.com recommends buying Manappuram Finance and Repco Home Finance and advises selling IndusInd Bank.
Ashwani Gujral of ashwanigujral.com is of the view that one can buy Bajaj Finserv and Dabur India and sell Ajanta Pharma.
According to Gaurav Bissa of LKP Securities, one may sell Jet Airways with a target of Rs 545.
Prakash Gaba of prakashgaba.com recommends buying Asian Paints with a target of Rs 1050 and feels that Bharti Airtel may test Rs 375.
Prakash Gaba of prakashgaba.com likes BHEL, Hindalco Industries and HDIL and feels that Jet Airways may test Rs 640.
Ashwani Gujral of ashwanigujral.com recommends buying Biocon and Dabur India and advises selling Tata Steel, Ajanta Pharma and Dish TV.
Ashwani Gujral of ashwanigujral.com recommends selling Just Dial, Dish TV and Ajanta Pharma.
According to Ashwani Gujral of ashwanigujral.com, Lupin may test Rs 1800-1900 while GATI can touch Rs 155.
Chandan Taparia of Anand Rathi Securities recommends buying Ajanta Pharma, IndusInd Bank and Arvind and feels that Dr Reddy‘s Laboratories may hit Rs 380.
Kunal Saraogi of Equityrush is of the view that one may buy Indiabulls Real Estate with a target of Rs 87.